Click for best price
Postpemic Era Celiac Disease Drugs Market Size, Share 2022
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
(Post-pandemic Era)-Global Celiac Disease Drugs Market Segment Research Report 2022?, which aims to sort out the development status and trends of the Celiac Disease Drugs industry at home and abroad, estimate the overall market scale of the Celiac Disease Drugs industry and the market share of major countries, Celiac Disease Drugs industry, and study and judge the downstream market demand of Celiac Disease Drugs through systematic research, Analyze the competition pattern of Celiac Disease Drugs, so as to help solve the pain points of various stakeholders in Celiac Disease Drugs industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Celiac Disease Drugs Market by Research Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Celiac Disease Drugs Market?
Roche
Merck
Johnson & Johnson
BiolineRx
Pfizer
Innovate Biopharmaceuticals
ImmusanT
Novartis
Bristol-Myers Squibb
Immunomedics
Major Type of Celiac Disease Drugs Covered in Research report:
First Line of Treatment
Second Line of Treatment
Application Segments Covered in Research Market
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
| Report Attributes |
Report Details |
| Report Title |
(Post-pandemic Era)-Global Celiac Disease Drugs Market Segment Research Report 2022 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
81 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
Table of Contents
Global Celiac Disease Drugs Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Celiac Disease Drugs Market by Value
2.2.1 Global Celiac Disease Drugs Revenue by Type
2.2.2 Global Celiac Disease Drugs Market by Value
2.3 Global Celiac Disease Drugs Market by Sales
2.3.1 Global Celiac Disease Drugs Sales by Type
2.3.2 Global Celiac Disease Drugs Market by Sales
3. The Major Driver of Celiac Disease Drugs Industry
3.1 Historical & Forecast Global Celiac Disease Drugs Sales and Revenue (2018-2028)
3.2 Largest Application for Celiac Disease Drugs (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Celiac Disease Drugs Market
4.1 Regional Market Size in Terms of Sales (2022 & 2028)
4.2 Regional Market Share in Terms of Revenue (2022 & 2028)
4.3 Concentration Ratio (CR5& CR10) of Celiac Disease Drugs Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Celiac Disease Drugs Sales (2018-2028)
5.1 Current and Estimated Sales Breakdown by Type (2018-2028)
5.2 Current and Estimated Sales Breakdown by Application (2018-2028)
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Celiac Disease Drugs Sales (2018-2028)
6.1 Current and Estimated Sales Breakdown by Type (2018-2028)
6.2 Current and Estimated Sales Breakdown by Application (2018-2028)
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Celiac Disease Drugs Sales (2018-2028)
7.1 Current and Estimated Sales Breakdown by Type (2018-2028)
7.2 Current and Estimated Sales Breakdown by Application (2018-2028)
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Celiac Disease Drugs Sales (2018-2028)
8.1 Current and Estimated Sales Breakdown by Type (2018-2028)
8.2 Current and Estimated Sales Breakdown by Application (2018-2028)
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Celiac Disease Drugs Sales (2018-2028)
9.1 Current and Estimated Sales Breakdown by Type (2018-2028)
9.2 Current and Estimated Sales Breakdown by Application (2018-2028)
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Celiac Disease Drugs Sales (2018-2028)
10.1 Current and Estimated Sales Breakdown by Type (2018-2028)
10.2 Current and Estimated Sales Breakdown by Application (2018-2028)
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Celiac Disease Drugs Sales (2018-2028)
11.1 Current and Estimated Sales Breakdown by Type (2018-2028)
11.2 Current and Estimated Sales Breakdown by Application (2018-2028)
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. South America Celiac Disease Drugs Sales (2018-2028)
12.1 Current and Estimated Sales Breakdown by Type (2018-2028)
12.2 Current and Estimated Sales Breakdown by Application (2018-2028)
12.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
12.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
13. Global Celiac Disease Drugs Average Price Trend
13.1 Market Price for Each Type of Celiac Disease Drugs in US (2018-2022)
13.2 Market Price for Each Type of Celiac Disease Drugs in Europe (2018-2022)
13.3 Market Price for Each Type of Celiac Disease Drugs in China (2018-2022)
13.4 Market Price for Each Type of Celiac Disease Drugs in Japan (2018-2022)
13.5 Market Price for Each Type of Celiac Disease Drugs in India (2018-2022)
13.6 Market Price for Each Type of Celiac Disease Drugs in Korea (2018-2022)
13.7 Market Price for Each Type of Celiac Disease Drugs in Southeast Asia (2018-2022)
13.8 Market Price for Each Type of Celiac Disease Drugs in South America (2018-2022)
14. Industrial Chain (Impact of COVID-19)
14.1 Celiac Disease Drugs Industrial Chain Analysis
14.2 Downstream
14.3 Impact of COVID-19
14.4 Post-pandemic Era
14.5 Technology Trends of Celiac Disease Drugs
15. Celiac Disease Drugs Competitive Landscape
15.1 Roche
15.1.1 Roche Company Profiles
15.1.2 Roche Product Introduction
15.1.3 Roche Celiac Disease Drugs Sales, Revenue (2018-2022)
15.1.4 Strategic initiatives
15.2 Merck
15.2.1 Merck Company Profiles
15.2.2 Merck Product Introduction
15.2.3 Merck Celiac Disease Drugs Sales, Revenue (2018-2022)
15.2.4 Strategic initiatives
15.3 Johnson & Johnson
15.3.1 Johnson & Johnson Company Profiles
15.3.2 Johnson & Johnson Product Introduction
15.3.3 Johnson & Johnson Celiac Disease Drugs Sales, Revenue (2018-2022)
15.3.4 Strategic initiatives
15.4 BiolineRx
15.4.1 BiolineRx Company Profiles
15.4.2 BiolineRx Product Introduction
15.4.3 BiolineRx Celiac Disease Drugs Sales, Revenue (2018-2022)
15.4.4 Strategic initiatives
15.5 Pfizer
15.5.1 Pfizer Company Profiles
15.5.2 Pfizer Product Introduction
15.5.3 Pfizer Celiac Disease Drugs Sales, Revenue (2018-2022)
15.5.4 Strategic initiatives
15.6 Innovate Biopharmaceuticals
15.6.1 Innovate Biopharmaceuticals Company Profiles
15.6.2 Innovate Biopharmaceuticals Product Introduction
15.6.3 Innovate Biopharmaceuticals Celiac Disease Drugs Sales, Revenue (2018-2022)
15.6.4 Strategic initiatives
15.7 ImmusanT
15.7.1 ImmusanT Company Profiles
15.7.2 ImmusanT Product Introduction
15.7.3 ImmusanT Celiac Disease Drugs Sales, Revenue (2018-2022)
15.7.4 Strategic initiatives
15.8 Novartis
15.8.1 Novartis Company Profiles
15.8.2 Novartis Product Introduction
15.8.3 Novartis Celiac Disease Drugs Sales, Revenue (2018-2022)
15.8.4 Strategic initiatives
15.9 Bristol-Myers Squibb
15.9.1 Bristol-Myers Squibb Company Profiles
15.9.2 Bristol-Myers Squibb Product Introduction
15.9.3 Bristol-Myers Squibb Celiac Disease Drugs Sales, Revenue (2018-2022)
15.9.4 Strategic initiatives
15.10 Immunomedics
15.10.1 Immunomedics Company Profiles
15.10.2 Immunomedics Product Introduction
15.10.3 Immunomedics Celiac Disease Drugs Sales, Revenue (2018-2022)
15.10.4 Strategic initiatives
16. Conclusion
17. Methodology and Data Source
LIST OF TABLES & FIGURES
List of Tables and Figures
Figure 1. Total Sales by Application of Celiac Disease Drugs Industry (Volume)
Figure 2. Celiac Disease Drugs Sales by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2028)
Figure 4. The Top 10 and 5 Players Market Share by Celiac Disease Drugs Revenue in 2022
Figure 5. US Celiac Disease Drugs Sales (2018-2028)
Figure 6. Sales Breakdown by Type (%)
Figure 7. Sales Breakdown by Type (%)
Figure 8. Sales Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Celiac Disease Drugs Sales (2018-2028)
Figure 12. Sales Breakdown by Type (%)
Figure 13. Sales Breakdown by Type (%)
Figure 14. Sales Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Celiac Disease Drugs Sales (2018-2028)
Figure 18. Sales Breakdown by Type (%)
Figure 19. Sales Breakdown by Type (%)
Figure 20. Sales Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Celiac Disease Drugs Sales (2018-2028)
Figure 25. Sales Breakdown by Type (%)
Figure 26. Sales Breakdown by Type (%)
Figure 27. Sales Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Celiac Disease Drugs Sales (2018-2028)
Figure 31. Sales Breakdown by Type (%)
Figure 32. Sales Breakdown by Type (%)
Figure 33. Sales Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Celiac Disease Drugs Sales (2018-2028)
Figure 37. Sales Breakdown by Type (%)
Figure 38. Sales Breakdown by Type (%)
Figure 39. Sales Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Celiac Disease Drugs Sales (2018-2028)
Figure 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Figure 44. Sales Breakdown by Type (%)
Figure 45. Sales Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Celiac Disease Drugs Revenue, by Type (Million USD) (2018-2028)
Table 4. Celiac Disease Drugs Sales, by Type (K Unit) (2018-2028)
Table 5. Celiac Disease Drugs Sales (K Unit) by Application (2018-2028)
Table 6. Celiac Disease Drugs Sales (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Sales (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2028)
Table 10. Ranking of Global Top Celiac Disease Drugs Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Celiac Disease Drugs Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 13. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 14. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 15. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Celiac Disease Drugs Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 19. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 20. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 21. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Celiac Disease Drugs Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 25. Table Current and Estimated Sales Breakdown by Type
Table 26. Current and Estimated Sales Breakdown by Type
Table 27. Current and Estimated Sales Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Celiac Disease Drugs Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 30. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 31. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 32. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Celiac Disease Drugs Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 36. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 37. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 38. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Celiac Disease Drugs Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 42. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 44. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Celiac Disease Drugs Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 48. Table Current and Estimated Sales Breakdown by Type (2018-2028)
Table 49. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Celiac Disease Drugs in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Celiac Disease Drugs in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Celiac Disease Drugs in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Celiac Disease Drugs in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Celiac Disease Drugs in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Celiac Disease Drugs in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Celiac Disease Drugs in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Roche Profiles
Table 61. Roche Celiac Disease Drugs Product Introduction
Table 62. Roche Celiac Disease Drugs Sales (Unit), Revenue (Million USD) (2018-2022)
Table 63. Roche Strategic initiatives
Table 64. Merck Profiles
Table 65. Merck Celiac Disease Drugs Product Introduction
Table 66. Merck Celiac Disease Drugs Sales (Unit), Revenue (Million USD) (2018-2022)
Table 67. Merck Strategic initiatives
Table 68. Johnson & Johnson Profiles
Table 69. Johnson & Johnson Celiac Disease Drugs Product Introduction
Table 70. Johnson & Johnson Celiac Disease Drugs Sales (Unit), Revenue (Million USD) (2018-2022)
Table 71. Johnson & Johnson Strategic initiatives
Table 72. BiolineRx Profiles
Table 73. BiolineRx Celiac Disease Drugs Product Introduction
Table 74. BiolineRx Celiac Disease Drugs Sales (Unit), Revenue (Million USD) (2018-2022)
Table 75. BiolineRx Strategic initiatives
Table 76. Pfizer Profiles
Table 77. Pfizer Celiac Disease Drugs Product Introduction
Table 78. Pfizer Celiac Disease Drugs Sales (Unit), Revenue (Million USD) (2018-2022)
Table 79. Pfizer Strategic initiatives
Table 80. Innovate Biopharmaceuticals Profiles
Table 81. Innovate Biopharmaceuticals Celiac Disease Drugs Product Introduction
Table 82. Innovate Biopharmaceuticals Celiac Disease Drugs Sales (Unit), Revenue (Million USD) (2018-2022)
Table 83. Innovate Biopharmaceuticals Strategic initiatives
Table 84. ImmusanT Profiles
Table 85. ImmusanT Celiac Disease Drugs Product Introduction
Table 86. ImmusanT Celiac Disease Drugs Sales (Unit), Revenue (Million USD) (2018-2022)
Table 87. ImmusanT Strategic initiatives
Table 88. Novartis Profiles
Table 89. Novartis Celiac Disease Drugs Product Introduction
Table 90. Novartis Celiac Disease Drugs Sales (Unit), Revenue (Million USD) (2018-2022)
Table 91. Novartis Strategic initiatives
Table 92. Bristol-Myers Squibb Profiles
Table 93. Bristol-Myers Squibb Celiac Disease Drugs Product Introduction
Table 94. Bristol-Myers Squibb Celiac Disease Drugs Sales (Unit), Revenue (Million USD) (2018-2022)
Table 95. Bristol-Myers Squibb Strategic initiatives
Table 97. Immunomedics Profiles
Table 98. Immunomedics Celiac Disease Drugs Product Introduction
Table 99. Immunomedics Celiac Disease Drugs Sales (Unit), Revenue (Million USD) (2018-2022)
Table 100. Immunomedics Strategic initiatives
